Cystathionine b-synthase (CBS) catalyzes the transsulfuration pathway and contributes, among other functions, to the generation of hydrogen sulfide. In view of the exceptionally high expression of CBS in the liver and the common interleukin-6 pathway used in the regulatory systems of hydrogen sulfide and hepcidin, we speculate that CBS is involved in body iron homeostasis. We found that CBS knockout (CBS 2/2 ) mice exhibited anemia and a significant increase in iron content in the serum, liver, spleen, and heart, along with severe damage to the liver, displaying a hemochromatosis-like phenotype. A high level of hepatic and serum hepcidin was also found. A major cause of the systemic iron overload is the reduced iron usage due to suppressed erythropoiesis, which is consistent with an increase in interleukin-6 and reduced expression of erythropoietin. Importantly, in the liver, absence of CBS caused both a reduction in the transcriptional factor nuclear factor erythroid 2-related factor-2 and an up-regulation of hepcidin that led to a decrease in the iron export protein ferroportin 1. The resulting suppression of iron export exacerbates iron retention, causing damage to hepatocytes. Finally, administration of CBSoverexpressing adenovirus into CBS mutant mice could partially reverse the iron-related phenotype. Conclusion: Our findings point to a critical role of CBS in iron homeostasis of the body, and the liver in particular; it is likely that a hemochromatosislike phenotype in patients can be induced by aberration not only in the expression of key molecules in the hepcidin pathway but also of those related to CBS. (HEPATOLOGY 2018;67:21-35) C ystathionine b-synthase (CBS) was first isolated in the liver by Braunstein et al.
C ystathionine b-synthase (CBS) was first isolated in the liver by Braunstein et al. (1) in 1969. The location of the human CBS gene is on chromosome 21 . (2) CBS is a key enzyme for hydrogen sulfide (H 2 S) production from L-cysteine, in addition to cystathionine gammalyase and 3-mercaptopyruvate sulfurtransferase. (2, 3) H 2 S has been implicated as the third endogenous gas transmitter, after nitric oxide and carbon monoxide, functioning in the brain as well as peripheral organs. (2, 3) CBS deficiency, induced by mutation in the CBS gene, is a rare autosomal recessive disorder characterized by highly elevated levels of total plasma homocysteine. (4) Patients not treated in infancy have multisystem disorders including arterial occlusions, venous thromboembolisms, osteoporosis, intellectual disabilities, psychiatric disorders, and dislocated lenses. (4, 5) Homozygous knockout mice (CBS 2/2 ) rarely survive past 4 weeks of age, (2) implying that CBS is essential for survival and development in mice.
It has been demonstrated that H 2 S has a significant effect on the regulation of proinflammatory cytokines including interleukin-6 (IL-6) (6) and signal transducer and activator of transcription 3 (STAT3) activity. (7) (8) (9) (10) Abbreviations: Ad, adenovirus; BMDM, bone marrow-derived macrophage; CBS, cystathionine b-synthase; CDDO-Im, 1[2-cyano-3,12-dioxooleana-1,9 (11) -dien-28-oyl] imidazole; DMT1, divalent metal transporter 1; EPO, erythropoietin; Fpn1, ferroportin 1; Ft-H, ferritin heavy chain; Ft-L, ferritin light chain; GSH, glutathione; H 2 S, hydrogen sulfide; Hb, hemoglobin; HFE, hemochromatosis protein; HJV, hemojuvelin; HO-1, heme oxygenase 1; IL-6, interleukin-6; IRE, iron-responsive element; IRP, iron regulatory protein; MBD5, methyl-CpG binding domain protein 5; Nqo1, nicotinamide adenine dinucleotide phosphate quinone dehydrogenase 1; NRF2, nuclear factor erythroid 2-related factor-2; Prdx1, peroxiredoxin 1; p-STAT3, phosphorylated STAT3; STAT3, signal transducer and activator of transcription 3; TfR, transferrin receptor.
On the other hand, it has also been concluded that during inflammation and infection, IL-6 directly regulates hepcidin expression through induction and subsequent promoter binding of STAT3. (8, 11) In addition, studies have shown that hepcidin is a central player in maintaining body iron homeostasis. (11) (12) (13) (14) (15) The confirmed association of H 2 S with IL-6 and STAT3 and the involvement of the IL-6/STAT3 pathway in hepcidin regulation prompted us to speculate that CBS has a physiological role in body iron homeostasis.
In the present study, we investigated the involvement of CBS in iron homeostasis by studying a number of iron-related parameters in the livers of normal (CBS 1/1 ), heterozygous (CBS
1/2
), and homozygous (CBS 2/2 ) knockout mice, including iron content in the serum and tissues, as well as the expression of hepcidin, the major cell-iron importers transferrin receptor 1 (TfR1) and divalent metal transporter 1 (DMT1), and the iron exporter ferroportin 1 (Fpn1). We observed abnormalities relating to body iron status and related erythropoiesis processes. To clarify the mechanisms underlying the impact of CBS deficiency on iron homeostasis, we further dissected the changes in the expression of key molecules involved in the regulation of body iron. These included iron regulatory protein 1 (IRP1), IRP2, hemojuvelin (HJV), TfR2, hemochromatosis protein (HFE), IL-6, and phosphorylated STAT3 (p-STAT3). Our results also prompted us to further examine the expression of erythropoietin (EPO), nuclear factor erythroid 2-related factor-2 (NRF2), as well as methyl-CpG binding domain protein 5 (MBD5) in the liver and ferritin heavy chain (Ft-H) in the intestine. To confirm the essential role of CBS in iron homeostasis, we performed rescue experiments by replenishing CBS in mutant mice. Our findings provide evidence for CBS being essential for body iron homeostasis.
Materials and Methods

MATERIALS
Unless otherwise stated, all chemicals including mouse monoclonal anti-b-actin were obtained from Sigma Chemical Company (St. Louis, MO). Antibodies, reagents, and kits purchased from other companies are listed in Supporting Table S1 . The CBS-overexpressing adenovirus (Ad-CBS) and blank virus (Ad-blank) with a titer of 1 3 10 11 plaque-forming units were constructed by Obio Technology Corp., Ltd. (Shanghai, China).
ANIMALS AND TREATMENTS
The CBS heterozygous knockout C57BL/6 mice (CBS 1/2 ) were a kind gift from Professor Rui Wang of Lakehead University (Thunder Bay, ON, Canada). The details of genotyping of CBS knockout mice are shown in Supporting Fig. S1 . To assess the effect of chemical inducers of NRF2 and the rescue effect of overexpression of CBS in CBS 2/2 mice, 1[2-cyano-3,12-dioxooleana-1,9 (11) -dien-28-oyl] imidazole (CDDO-Im; 16.3 mg/kg body weight) or vehicle was orally administered, and 10 mL Ad-CBS or Ad-blank was intravenously administered to CBS 2/2 mice, respectively. Liver tissue was obtained 11 hours or 1 week after the treatments. All animal care and experimental protocols were performed according to the Animal Management Rules of the Ministry of Health of China and approved by the Animal Ethics Committees of Fudan University and The Chinese University of Hong Kong.
decapitated. Blood samples were collected into heparinized syringes for the determination of serum iron, unsaturated iron-binding capacity, total iron-binding capacity, and transferrin saturation. Mice were perfused with phosphate-buffered saline, and the liver, heart, spleen, and intestine were removed, excised, and rinsed in phosphate-buffered saline; dried; and weighed (16, 17) for total RNA extraction, protein determination, and iron measurement.
SERUM IRON, TRANSFERRIN SATURATION, FERRITIN, AND HEMATOLOGIC PARAMETERS
Serum iron and unsaturated iron-binding capacity were measured using commercial kits as described. (18, 19) Total iron binding capacity (micrograms per deciliter; 5 serum iron 1 unsaturated iron-binding capacity) and transferrin saturation (5 serum iron/total iron-binding capacity 3 100) were calculated. Serum ferritin levels were determined using an ELECSYS 2010 analyzer (Roche Diagnostics GmbH), and hematologic parameters (red blood cell count, hemoglobin [Hb] , and hematocrit) were measured as described. (18, 19) ISOLATION OF TOTAL RNA AND QUANTITATIVE REAL-TIME PCR Total RNA extraction and complementary DNA preparation were performed using TRIzol reagent and the RevertAid First Strand cDNA Synthesis Kit, respectively, in accordance with the instructions of the manufacturers. Real-time PCR was carried out using FastStart Universal SYBR Green Master and LightCycler96. The specific pairs of primers of mouse bactin, hepcidin, EPO, NRF2, IRP1, IRP2, Ft-H, TfR2, HJV, MBD5, nicotinamide adenine dinucleotide phosphate quinone dehydrogenase 1 (Nqo1), peroxiredoxin 1 (Prdx1), Fpn1, and heme oxygenase 1 (HO-1) are listed in Supporting Table S2 . (20, 21) The cycle threshold value of each target gene was normalized to that of the b-actin mRNA. Relative gene expression was calculated by the 2 -DDCT method.
WESTERN BLOT ANALYSIS
The tissue was washed and homogenized as described. (22) Aliquots of the extract containing about 30 lg of protein were loaded and run on a single track of 12% (for Ft-H and ferritin light chain [Ft-L]), 8% (for MBD5), or 10% (for others) sodium dodecyl sulfate-polyacrylamide gel electrophoresis under reducing conditions and subsequently transferred to a pure nitrocellulose membrane. The blots were blocked and then incubated with primary antibodies: rabbit anti-CBS (1:1,000), mouse anti-TfR1 (1:500), rabbit anti-Fpn1 (1:1,000), rabbit anti-DMT1 (1:1,000), rabbit anti-IRP1 (1:1,000), rabbit anti-IRP2 (1:1,000), rabbit anti-Ft-L (1:1,000), rabbit anti-Ft-H (1:1,000), rabbit anti-TfR2 (1:1,000), goat anti-HJV (1:1,000), rabbit anti-EPO (1:100), rabbit anti-MBD5 (1:1,000), rabbit anti-NRF2 (1:1,000), mouse anti-STAT3 (1:1,000), and rabbit anti-p-STAT3 (1:1,000), overnight at 48C. After being washed, the blots were incubated with goat antirabbit or antimouse IRDye 800 CW secondary antibody (1:20,000) for 2 hours at 378C. The intensity of the specific bands was detected and analyzed with the Odyssey infrared imaging system (Li-Cor). To ensure even loading of the samples, the same membrane was probed with rabbit anti-b-actin polyclonal antibody at a 1:2,000 dilution.
IMMUNOFLUORESCENCE AND HEMATOXYLIN-EOSIN STAINING
Immunostaining was carried out as described. (20) In brief, mice were perfused with 0.9% saline and 4% paraformaldehyde. Liver tissues were immersed in cryo-embedding medium (optimal cutting temperature) and then sectioned into 10-mm-thick slices using a cryotome (Leica Microsystems, Wetzlar, Germany). Slices were incubated in blocking solution, followed by overnight incubation at 48C with primary antibodies: rabbit anti-CBS (1:50), rabbit anti-EPO (1:10), rabbit anti-NRF2 (1:50), and rabbit antihepcidin (1:50). After washing with phosphate-buffered saline, the slides were incubated with Alex Fluor 488-conjugated secondary antibodies for 1 hour at 378C. Nuclei were counterstained with 4 0 ,6-diamidino-2-phenylindole. Slides with immunofluorescence staining were visualized with a confocal microscope (Carl Zeiss, Heidenheim, Germany). Images from at least four fields each from three mice were examined. The degree of tissue damage was examined by staining with a standard hematoxylin-eosin stain.
TISSUE IRON MEASUREMENT
The total iron in the tissues was determined using a graphite furnace atomic absorption spectrophotometer as described. (15) In brief, tissues were homogenized in 20 mM 4-(2-hydroxyethyl)-1-piperazine ethanesulfonic acid, followed by digestion in an equal volume of ultrapure nitric acid, and then measured with a graphite furnace atomic absorption spectrophotometer (Perkin-Elmer; Analyst 100).
BONE MARROW-DERIVED MACROPHAGES AND CELLULAR IRON MEASUREMENT BY CALCEIN-AM
Bone marrow-derived macrophages (BMDMs) were prepared as described, with some modifications. (23) In brief, the bone was cut from the knee joint. Roswell Park Memorial Institute medium from a 10-mL syringe with a 26-G needle was flushed into the joint and then collected. The entire medium was incubated with NH 4 Cl solution on ice for 10 minutes to remove red blood cells, which were then collected for centrifuging at 300-400g at 48C for 5 minutes. Then, BMDMs were washed, cultured in differentiation medium (Roswell Park Memorial Institute medium with 40 ng/mL macrophage colony-stimulating factor), and incubated in fresh medium every 2-3 days. For cellular iron measurement, BMDMs were harvested and stained with 0.5 lM calcein-AM for 15 minutes before flow-cytometric analysis (FACSCalibur; Becton-Dickinson). (24) 
ENZYME-LINKED IMMUNOSORBENT ASSAY
Serum IL-6 and hepcidin concentrations were determined using an enzyme-linked immunosorbent assay kit according to the manufacturer's instructions, as described. (25) 
MEASUREMENTS OF GLUTATHIONE
The levels of glutathione (GSH) in the liver were measured at 405 nm spectrophotometrically by assay kits according to the manufacturer's instructions.
STATISTICAL ANALYSIS
Statistical analyses were performed using Graphpad Prism. Data were presented as mean 6 SEM. All differences between the means were determined by two-way analysis of variance. A probability value of P < 0.05 was taken to be statistically significant.
Results
REDUCED BODY WEIGHT AND INCREASED HEPATIC IRON AND DAMAGE IN CBS 2/2 MICE
The complete absence of CBS led to a severe decline in body weight (Fig. 1A,B) . The liver volumes of CBS 2/2 mice were much smaller than those of CBS 1/1 or CBS 1/2 mice, and the color of the liver in CBS 2/2 mice was white rather than dark brown, as was the case for livers of CBS 1/1 or CBS 1/2 mice (Fig.  1C) . Hematoxylin-eosin staining analysis of liver sections (Fig. 1D) mice. In addition, western blot analysis demonstrated that the contents of Ft-L (Fig. 2H) and Ft-H (Fig. 2I ) in the liver were markedly higher in CBS 2/2 mice than in CBS 1/1 or CBS 1/2 mice at the age of 3 weeks. Between the CBS 1/1 and the CBS 1/2 mice, there were no differences in serum iron ( Fig. 2A) , transferrin saturation (Fig. 2B ), ferritin levels ( Fig.  2C ), IL-6 (Fig. 2D ), or hepcidin (Fig. 2E) . Iron contents in the spleen (Fig. 2F) and heart (Fig. 2G) , , and CBS 1/1 mice and iron contents (G) in the livers of newborn, 1-week-old, 2-week-old, and 3-week-old CBS however, were significantly higher in CBS 1/2 than in CBS 1/1 mice.
IMPACT OF CBS DEFICIENCY ON HEPCIDIN AND ITS REGULATORY GENES' EXPRESSION IN LIVER
To investigate why the absence of CBS was able to induce hemochromatosis-like phenotypes in mice, we further investigated the expression of hepcidin and five key molecules involved in the regulation of hepcidin: IL-6, p-STAT3, HFE, HJV, and TfR2 mRNAs and/ or proteins (25) (26) (27) in the liver of CBS
, CBS 1/2 , and CBS 2/2 mice. Quantitative RT-PCR showed no significant differences in the expression of HFE mRNA (Fig. 3C) (Fig. 3A,B) , IL-6 mRNA (Fig. 3D) , and p-STAT3 protein (Fig. 3G) was observably higher and that the expression of HJV (Fig. 3E,H) and TfR2 (Fig. 3F,I ) mRNAs and proteins was lower in the liver of CBS To understand the effects of the absence of CBS and the increased hepcidin on the expression of celliron transporters, we further investigated the expression of three key cell-iron transporters, TfR1, DMT1, and Fpn1, in the livers of mice. Western blot analysis showed that the expression of TfR1 (Fig. 4A) , DMT1 (Fig. 4B) , and Fpn1 (Fig. 4C ) proteins in the liver was and CBS 1/2 mice. In addition to hepcidin, (14, 28) expression of TfR1, DMT1, and Fpn1 is regulated by IRPs (29) (30) (31) ; and therefore, expression of IRP1 and IRP2 was also investigated. Quantitative real-time PCR and western blot analysis demonstrated that the levels of both IRP1 (Fig. 4D,G) and IRP2 (Fig.  4E,H ) mRNAs and proteins were prominently lower in CBS 2/2 than in CBS 1/1 and CBS 1/2 mice. Also, the levels of IRP1 mRNA (Fig. 4D) and protein (Fig.   4G ) and IRP2 protein (Fig. 4H) were significantly lower in CBS 1/2 than in CBS 1/1 mice.
EFFECTS OF CBS KNOCKDOWN ON PROTEINS RELATED TO INTESTINAL IRON ABSORPTION
To further clarify the possible mechanisms involved in the development of the iron-overload phenotype, we 
, CBS
1/2 , and CBS 1/1 mice. Data are presented as means 6 SEM (n 5 6). *P < 0.05, **P < 0.01, and ***P < 0.001 versus CBS 1/1 mice; # P < 0.05, ## P < 0.01, and ### P < 0.001 versus CBS 1/2 mice. Abbreviation: DAPI, 4 0 ,6-diamidino-2-phenylindole.
then assessed changes in the expression of Ft-H in the intestine and MBD5 in the liver and intestine of CBS
, and CBS 2/2 mice. These two parameters were investigated because intestinal Ft-H has been demonstrated to be required for an accurate control of iron absorption, (32, 33) while MBD5 has an inhibiting effect on iron absorption in the intestine. (34) Quantitative real-time PCR and western blot analysis demonstrated that there were no differences in the contents of Ft-H (Supporting Fig. S2A,B Fig. S2C ) was reduced in the intestine of CBS 2/2 mice. Expression of MBD5 (Fig. 4F,I ) in the liver was also observably lower in CBS 2/2 mice.
CBS KNOCKDOWN SUPPRESSED ERYTHROPOIESIS AND RESULTS IN ANEMIA
We also investigated the expression of EPO in the livers of CBS , and CBS 1/2 mice because EPO has been demonstrated to be involved in the regulation of hepcidin expression. (35) We found that expression of EPO mRNA (Fig. 5A) and protein (Fig. 5B) in the liver was prominently lower in CBS 2/2 than in CBS 1/1 and CBS 1/2 mice. Immunofluorescence staining of EPO showed consistent results (Fig. 5C ). There were no significant differences in the expression of EPO (Fig. 5A-C , and CBS 1/1 mice. Data are presented as means 6 SEM (n 5 6). *P < 0.05, **P < 0.01, and ***P < 0.001 versus CBS Table S3 ). Western blot analysis demonstrated that the expression of Ft-L (Fig. 5D ) in BMDM cells from CBS 2/2 mice was significantly higher than in those from CBS 1/1 and CBS 
CBS KNOCKDOWN REDUCED THE EXPRESSION OF NRF2 AND ITS TARGET GENES AS WELL AS GSH CONTENT IN THE LIVERS OF MICE
We then investigated the expression of NRF2 in the liver of CBS NRF2 is known to affect Fpn1 expression and celliron release. (36) We found that the expression of NFR2 mRNA (Fig. 6A) and protein (Fig. 6B) , NFR2 target genes Nqo1 (Fig. 6D) and Prdx1 (Fig. 6E) mRNA (but not HO-1 mRNA; Fig. 6F ), and GSH content (Fig. 6G) in the liver were prominently lower in CBS 2/2 than in CBS 1/1 and CBS 1/2 mice.
Immunofluorescence staining of NRF2 showed consistent results (Fig. 6C) , and there were no significant differences in the expression of NRF2 mRNA and protein ( Fig. 6A-C) , Nqo1 (Fig. 6D) and Prdx1 (Fig. 6E) , HO-1 mRNA (Fig. 6F ) and GSH content ( , and CBS 1/1 mice. Data are presented as means 6 SEM (n 5 6). (H-K) CDDO-Im increased NRF2 expression as well as partially reversed the iron-overload phenotype in CBS 2/2 mice. Iron content (H) and expression of NRF2 (I,K) and Fpn1 (J,K) proteins in the liver of CBS 2/2 mice treated with or without CDDO-Im. *P < 0.05, **P < 0.01 and ***P < 0.001 versus CBS (Fig.  6I,K) and Fpn1 (Fig. 6J,K) proteins was significantly increased in the liver of CBS 2/2 mice after treatment with CDDO-Im. Iron content (Fig. 6H) was lower in the liver of CBS 2/2 mice treated with CDDO-Im compared to mice without. These findings showed that treatment with a chemical inducer of NRF2 can increase NRF2 expression as well as partially reverse the iron-overload phenotype induced by the complete absence of CBS.
REPLENISHMENT OF CBS PARTIALLY REVERSED THE IRON-RELATED PHENOTYPE IN CBS
2/2 MICE Finally, we examined the effects of CBS overexpression on iron content in the serum and liver and on the expression of NRF2, Ft-L, Ft-H, and CBS in the liver. CBS 2/2 mice (2 weeks old) were treated with 10 lL of Ad-CBS or Ad-blank by tail intravenous injection, and 7 days later the relevant measurements were performed. Treatment with Ad-CBS was found to significantly inhibit the increased iron content in the liver and serum, the increased Ft-L and Ft-H proteins in the liver, and the reduced expression of CBS and NRF2 proteins in the livers of CBS 2/2 mice. Iron content in the liver (Fig. 7A) and serum (Fig. 7B) and Ft-L (Fig. 7E) and Ft-H (Fig. 7F) proteins in the liver were significantly lower, and the expression of CBS (Fig. 7C) and NRF2 (Fig. 7D) proteins was higher, in CBS 2/2 mice treated with Ad-CBS than in those with Ad-blank. The data demonstrate that Ad-CBS can increase CBS expression and partially reverse the iron-related phenotype induced by CBS deficiency.
Discussion
In the present study, we demonstrate that the complete absence of CBS (CBS 2/2 ) can induce a significant increase in iron, transferrin saturation, and ferritin content in the serum; in iron content and Ft-L and Ft-H expression in the liver; and in iron levels in the spleen and heart and causes severe damage to the liver in 3-week-old mice. These effects are accompanied by significant reduction in body weight and liver volume. The increase in iron in the liver manifests in mice aged 1 week and aggravates with age, indicating a primary effect of iron dyshomeostasis on health and development. Treatment with Ad-CBS significantly reduced iron content in the liver and serum and Ft-L and Ft-H levels in the livers of CBS 2/2 mice, showing that replenishment of the absent CBS can reverse the iron-related phenotype in CBS 2/2 mice. These findings support the hypothesis that CBS is essential for physiological iron metabolism.
The phenotype induced by the absence of CBS is very similar to that found in hemochromatosis, a genetic iron-overload disorder characterized by mutations in one of the critical genes that control hepcidin expression. (37) These genes include the HFE, (25) HJV, (27) TfR2, (26) mothers against decapentaplegic homolog 4, and bone morphogenetic protein 6 (38, 39) genes. Although hemochromatosis could be a result of the mutations of different genes, except for the time of onset, the phenotype is generally the same as the targets of iron toxicity are identical, including the liver and heart. Because the pathogenic basis of all forms of hemochromatosis is hepcidin deficiency, (37) it is of interest to determine if the hemochromatosis-like phenotypes in CBS 2/2 mice are also due to aberrations in hepcidin expression. Intriguingly, our data argue against this scenario. Contrary to our expectation, CBS deficiency led to a significant increase, rather than a decrease, in hepcidin mRNA and protein in the liver and serum. This was accompanied by low expression of HJV and TfR2, high expression of IL-6 and p-STAT3, and unaltered levels of HFE. Because low HJV and TfR2 levels are expected to reduce hepcidin expression, the level of hepcidin in the CBS 2/2 mice is not being regulated by these genes. On the other hand, increased expression of IL-6 and p-STAT3 in the absence of CBS could be driving the expression of hepcidin in these mice. In addition, iron retention in the liver is a strong inducer for increasing the expression of hepcidin. (11, 12) Therefore, the increase in hepcidin transcript levels could be due primarily to the IL-6/p-STAT3 pathway and secondarily to iron retention under the conditions of CBS deficiency. Taken together, the results highlight that a hemochromatosis-like phenotype could be induced even in the presence of a high level of hepcidin.
A major question to addess then is the cause of iron retention observed in systemic circulation and the liver that up-regulates hepcidin expression. We found that knockdown of CBS markedly reduced EPO expression in the liver and Hb in the blood and increased Ft-L and iron content in BMDMs. EPO is a glycoprotein hormone that stimulates erythropoiesis. (37) Reduced EPO could lead to a reduction in erythropoiesis and thus the amount of iron used for erythropoiesis; this is evidenced by the increased Ft-L and iron levels in BMDMs and by the reduced Hb in the blood. In addition, it has been well documented that erythropoiesis could be inhibited by IL-6. (40, 41) CBS deficiency has been shown to correlate with increased IL-6 levels. (42) In the present study, we also found that IL-6 expression and content in the liver and serum were significantly higher in CBS 2/2 than in CBS 1/2 and CBS 1/1 mice. Therefore, highly suppressed erythropoiesis as a consequence of reduced EPO and increased IL-6 is likely the major reason for the increased iron and ferritin content in the serum and the iron overload in the liver and other organs, that is, hemochromatosis phenotype in the CBS 2/2 mice. In turn, the iron retention and the increased IL-6/p-STAT3 up-regulate hepcidin expression.
Mammalian iron metabolism is regulated systemically by hepcidin and cellularly by IRPs. (43, 44) In most types of cells, iron balance is mainly dependent on the expression of three key cell-iron transporters, Fpn1 (exporter), TfR1, and DMT1 (importers). Studies have shown that their expression is regulated by not only IRPs (29) (30) (31) but also hepcidin. Fpn1 is a receptor for hepcidin, internalized and subsequently degraded after binding with hepcidin. (45) TfR1 has been found to be directly inhibited by hepcidin in different types of cells (14, 15, 46) , and the ability of hepcidin to downregulate DMT1 expression has also been demonstrated in the intestine through proteasome internalization and degradation. (28) It has been well demonstrated that the expression of TfR1, DMT1, and Fpn1 is coordinately regulated by the IRP/iron-responsive element (IRE) system, (43, 44, 46, 47) positively for the 3 0 untranslated region IRE motif in TfR1 and the 3 0 untranslated region IRE motif in DMT1 and negatively for the 5 0 untranslated region IRE motif in Fpn1. Hepcidin and the IRP/IRE system are integrated together to precisely control expression of Fpn1, TfR1, and DMT1 under normal conditions. In the present study, we found that the absence of CBS led to a significant reduction in the expression of TfR1, DMT1, and Fpn1, as well as that of IRP1 and IRP2 in the liver. Based on our current understanding of IRP/IRE system-regulated TfR1, DMT1, and Fpn1 expression, the reduction of TfR1 and DMT1 expression should be a secondary effect of iron accumulation in livers, likely through changes to the IRP/IRE level. Therefore, it is believed that the iron overload in the liver is unlikely to be due to increased active iron uptake but rather to reduced iron export by reduced expression of Fpn1, which could partly be caused by increased hepcidin level.
In CBS 2/2 mice, another factor that could contribute to reduced expression of Fpn1 is NRF2. NRF2, a transcription factor that regulates antioxidant genes, has been known to affect Fpn1 expression and celliron release (36) and can be activated by the H 2 S donors GYY4137 (48) and sodium hydrosulfide. (49) Impaired NRF2 expression can reduce Fpn1 transcription and then diminish iron egress in mouse and human cells. (36, 50) In the present study, we demonstrated that CBS 2/2 markedly reduced the expression of NRF2 and its target genes, including Nqo1 and Prdx1 mRNA, as well as GSH content in the liver. Treatment with CDDO-Im, a chemical inducer of NRF2, could significantly increase the expression of NRF2 and Fpn1 and reduced iron content in the livers of CBS 2/2 mice, partially reversing the iron-overload phenotype. These findings imply that the significant reduction of NRF2 in the liver may also play an important role in the reduction of Fpn1 expression and iron accumulation in hepatocytes or other organ cells in CBS 2/2 mice. In addition to hepcidin, intestinal Ft-H has recently been shown to be required for accurate control of iron absorption. (32, 33) Body iron stores, transferrin saturation, intestinal Fpn1 protein, and 59 Fe absorption were demonstrated to increase significantly in mice with an intestinal Ft-H gene deletion. (33) Also, a recent study showed that deletion of MBD5 in mice induces an iron-overload phenotype. Iron and ferritin levels in the liver and serum were markedly higher and intestinal Ft-H mRNA levels lower in mice with a global deletion of MBD5 compared to their wild-type littermates. (34) These data indicate that hepcidin-mediated regulation alone is insufficient to restrict iron absorption and that additional pathways, such as the MBD5/ Ft-H pathway, may be required to regulate iron absorption from intestinal cells. However, in the study, there was a decrease of DMT1 and no change in Fpn1 level, which is not easy to explain for increased iron absorption because this would seem inconsistent with the idea that reduction or knockout of Ft-H increases iron absorption by increasing Fpn1 in the intestine. (33) Thus, the exact relationship between MBD5 and the increased iron absorption is still not fully understood. Here, we demonstrated that the absence of CBS exerted an inhibitory action on the expression of MBD5 in the liver and intestine but had no effect on the expression of Ft-H in the intestine, implying that the control of iron absorption by MBD5 could be rather complicated and needs to be addressed in future studies.
In summary, we demonstrated that the complete absence of CBS results in a remarkable increase in iron content in the serum, in iron overload in the liver and other organs, and in severe liver damage reminiscent of hemochromatosis. Based on the results of our mechanistic studies, we hypothesize that a block in erythropoiesis, caused by increased IL-6 signaling and reduced EPO expression, is the major cause of this hemochromatosis-like phenotype. The rise of hepcidin is the result of increased IL-6 signaling and is also secondary to iron retention. Reduced Fpn1 expression due to raised hepcidin level and reduced NRF2 exacerbates liver iron retention and damage. This model is summarized schematically in Fig. 8 . In conclusion, our findings highlight a previously unknown but critical role of CBS in iron homeostasis of the body, and in the liver in particular. Its specific role in other major organs, including the brain, awaits further investigations. Also, a hemochromatosis-like phenotype could be induced by aberrations not only in the expression of key molecules in the hepcidin regulatory pathway but also of those involving CBS.
FIG. 8.
A hypothetical scheme for the mechanisms of iron overload in CBS 2/2 mice. Absence of CBS produces multiple effects, including decreased expression of EPO and increased IL-6 expression in the liver, both of which cause suppression of erythropoiesis. The resulting reduction in iron usage underlies the systematic iron overload. An increase in hepcidin expression could be due primarily to the enhanced IL-6/p-STAT3 pathway and secondarily to iron retention under the conditions of CBS deficiency. In addition, CBS 2/2 causes a decrease in NRF2, leading to decreased Fpn1 expression and further iron retention in the liver. CBS
2/2
-induced reduction in MBD5 may have an effect on iron absorption in the intestine that contributes to iron retention.
